Picture of Aroa Biosurgery logo

ARX — Aroa Biosurgery Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m-7.94%
3m-4.16%
6m-25.7%
1yr-34.45%
Volume Change (%)
10d/3m+52.05%
Price vs... (%)
52w High-50.19%
50d MA-16.42%
200d MA-29.54%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-7.21%
Return on Equity-10.55%
Operating Margin-19.26%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202331st Mar 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Aroa Biosurgery EPS forecast chart

Profile Summary

Aroa Biosurgery Limited is a New Zealand-based regenerative medicine company. The Company develops, manufactures and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction using its extracellular matrix (ECM) technology. Its AROA ECM is a platform technology, containing biomaterial complex mix of biological molecules that is building block for range of soft tissue repair products. Its products include Endoform Antimicrobial Restorative Bioscaffold, Endoform Natural Restorative Bioscaffold, Myriad Matrix, Myriad Morcells and Reinforced Bioscaffolds. Its Endoform Antimicrobial Restorative Bioscaffold and Endoform Natural Restorative Bioscaffold are ECM products for the management of acute and chronic wounds. Its Myriad Matrix is used for soft tissue repair, reinforcement and complex wounds, specifically designed to maximize tissue repair while providing versatility and adaptability across a range of surgical applications.

Directors

Last Annual
March 31st, 2022
Last Interim
March 31st, 2022
Incorporated
September 21st, 2007
Public Since
July 24th, 2020
No. of Employees
16
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
342,461,133

ARX Share Price Performance

Upcoming Events for ARX

Aroa Biosurgery Ltd Annual Shareholders Meeting

Aroa Biosurgery Ltd Annual Shareholders Meeting

Half Year 2023 Aroa Biosurgery Ltd Earnings Release

Similar to ARX

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Allegra Orthopaedics logo

Allegra Orthopaedics

au flag iconAustralian Stock Exchange - SEATS

Picture of Analytica logo

Analytica

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email